Diabetes, Obesity & Metabolism Research
Metabolic dysregulation may cause a number of chronic diseases and conditions. Diabetes, obesity, fatty liver disease, and atherosclerosis are among the most common, costly, and preventable of all health problems, and mainly due to dysregulation of lipid, glucose or energy metabolism. Diabetes, obesity, and non-alcoholic fatty liver disease account for 9.4%, 34%, and 30% of the US population, respectively. Atherosclerosis is the major cause for coronary heart disease, the No. 1 killer in the US. The Diabetes, Obesity and Metabolism Research Focus Area at NEOMED aims to build a collaborative internationally-recognized Center of Excellence for fundamental and translational research in diabetes, obesity and metabolism. The members of this group have expertise in studying bile acid, glucose, lipid and lipoprotein metabolism.
Yanqiao Zhang, M.D., FAHA, Director
John Chiang, Ph.D.
Yoon-Kwang Lee, Ph.D.
James Hardwick, Ph.D.
Takhar Kasumov, Ph.D.
Liya Yin, M.D., Ph.D.
Priya Raman, Ph.D.
Jessica Ferrell, Ph.D.
News & Stories
Northeast Ohio Medical University researcher and professor of integrative medical sciences, Yanqiao Zhang, M.D., has received a five-year, $2.5 million […]
For individuals with alcoholic fatty liver disease, abstaining from drinking has been the only way to stop the progression. There may […]